Abstract
221 Anemia treatment, clinical event rates, and healthcare resource utilization (HCRU) in a US prevalent hemodialysis (HD) cohort hyporesponsive to erythropoietin stimulating agents (ESAs)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
